Kindred Biosciences (KIN) Tops Q4 EPS by 7c

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 11/4/2026

1. AAPL
2. AMD
3. PLTR
4. DOX
5. VRTX
6. CHKP
7. CRWD
8. ON
9. INSP
10. CVI

Go back to Kindred Biosciences (KIN) Tops Q4 EPS by 7c

Kindred Biosciences Announces Fourth Quarter and Year-End 2016 Financial Results

March 1, 2017 4:01 PM EST

SAN FRANCISCO, March 1, 2017 /PRNewswire/ -- Kindred Biosciences, Inc. (NASDAQ: KIN) (KindredBio), a biopharmaceutical company focused on saving and improving the lives of pets, today announced financial results for the fourth quarter and full year ended December 31, 2016.  

"We are very pleased with the progress of Mirataz and Zimeta, including the recently announced approval of the efficacy technical section for Mirataz," stated Richard Chin, M.D., President and CEO of KindredBio. "We are looking forward to the transition to a... More